Retrospective Analysis of Dronedarone Versus Amiodarone on Outcomes Following Radiofrequency Ablation for Atrial Fibrillation
British Journal of Hospital Medicine · 2026
DOI: 10.31083/bjhm53024 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Hospital Medicine, 2026. Verfasst von Yun Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, 300192 Tianjin, China. Hauptthemen laut MEDLINE: Dronedarone, Atrial Fibrillation, Amiodarone, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Municipal Health Commission Science and Technology Project.
Abstract (Originalsprache)
Aims/Background: Pharmacological therapy can enhance the therapeutic efficacy of radiofrequency ablation (RFA) for atrial fibrillation (AF) and reduce the risk of recurrence. Dronedarone and amiodarone are two commonly prescribed adjuvant medications. However, no consensus exists on which agent demonstrates superior efficacy. This study aimed to compare the effects of dronedarone and amiodarone on the prognosis of patients undergoing RFA for AF, thereby providing evidence-based guidance for clinical medication selection.
Methods
A retrospective analysis was conducted on AF patients who underwent RFA in Tianjin Fourth Central Hospital between August 2022 and May 2023. Patients were assigned to a dronedarone group (n = 50), and an amiodarone group (n = 59) based on the postoperative medication received. Postoperatively, patients were treated with either dronedarone hydrochloride tablets or amiodarone hydrochloride tablets for 6 months. Long-term electrocardiographic monitoring (7-day duration via 5G network) was performed at 1, 3, 6, and 12 months postoperatively to assess recurrence of atrial arrhythmias. Follow-up assessments at the same intervals included thyroid, liver, and renal function, left atrial diameter (LAD), left ventricular ejection fraction (LVEF), and QT interval.
Results
No statistically significant difference was observed in AF recurrence between the two groups (p > 0.05). The incidence of thyroid dysfunction was significantly lower in the dronedarone group compared with the amiodarone group (p < 0.05), whereas other adverse events showed no significant difference (p > 0.05). In both groups, postoperative LVEF was significantly higher than preoperative values (p < 0.05), and LAD was significantly reduced (p < 0.05). Comparing the two groups, postoperative LAD was significantly smaller in the dronedarone group than in the amiodarone group (p < 0.05), while postoperative LVEF exhibited no statistically significant difference (p > 0.05).
Conclusion
Dronedarone and amiodarone are similarly effective in reducing the AF recurrence after RFA. However, dronedarone is associated with a lower risk of thyroid dysfunction and confers greater improvement in left atrial remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, 300192 Tianjin, China.
- Research Department, Characteristic Medical Center of PAP, 300162 Tianjin, China.
- Department of Military Patient Management, The 987th Hospital of the Joint Logistics Support Force of PLA, 721000 Baoji, Shaanxi, China.
- Medical Service Department, The 980th Hospital of the Joint Logistics Support Force of PLA, 050082 Shijiazhuang, Hebei, China.
Förderung
- Tianjin Municipal Health Commission Science and Technology Project
Zitieren
APA
Shi, Y., Shi, X., Li, H., Gu, X., Zhang, T., & Zhang, G. (2026). Retrospective Analysis of Dronedarone Versus Amiodarone on Outcomes Following Radiofrequency Ablation for Atrial Fibrillation. British Journal of Hospital Medicine. https://doi.org/10.31083/bjhm53024
Vancouver
Shi Y, Shi X, Li H, Gu X, Zhang T, Zhang G. Retrospective Analysis of Dronedarone Versus Amiodarone on Outcomes Following Radiofrequency Ablation for Atrial Fibrillation. British Journal of Hospital Medicine. 2026. doi:10.31083/bjhm53024
BibTeX
@article{Shi2026,
author = {Shi, Yun and Shi, Xueying and Li, Huanming and Gu, Xiufeng and Zhang, Ting and Zhang, Guanyi},
title = {Retrospective Analysis of Dronedarone Versus Amiodarone on Outcomes Following Radiofrequency Ablation for Atrial Fibrillation},
journal = {British Journal of Hospital Medicine},
year = {2026},
doi = {10.31083/bjhm53024}
}
EUVIMED